Aro Biotherapeutics Appoints Biotechnology Executive Dr. Christopher Mirabelli to its Board of Directors and Nucleic Acid Therapeutics Expert Dr. Masad Damha to its Scientific Advisory Board

Aro Collaboration with Ionis Advances with Option Exercise

Aro Biotherapeutics Appoints Leading Cancer Biologist Dr. Martin McMahon and Protein Structure and Design Expert Dr. Ronald Swanson to its Scientific Advisory Board

Aro Biotherapeutics and Ionis Enter Licensing and Collaboration Agreement Focused on Cell-Specific Delivery of Antisense Oligonucleotides

Aro Biotherapeutics Names Seasoned Biopharma Industry Veteran Scott Greenberg as Vice President, Business Development and Alliance Management

Aro Biotherapeutics Debuts Lead Centyrin Candidate at 2019 OTS Meeting

Aro Biotherapeutics Appoints Anthony Tolcher, MD, to Scientific Advisory Board

Aro Biotherapeutics to Present Corporate Overview at BioCentury Future Leader’s In the Biotech Industry Conference

Aro Biotherapeutics to Present Data on Lead Program, ABX900, at AACR

Aro Biotherapeutics Debuts Lead Centyrin Candidate at 2019 OTS Meeting

Aro Biotherapeutics Raises $13 Million and Establishes Leadership Team to Develop Next Generation of Protein Therapeutics